Calyxt Inc. began a follow-on public offering of 3,050,000 common shares.
The New Brighton, Minn.-based company intends to grant underwriters a 30-day option to buy up to an additional 457,500 common shares.
Citigroup, Goldman Sachs & Co. LLC and Jefferies are acting as book-running managers with Wells Fargo Securities as lead manager and BMO Capital Markets as co-manager for the proposed offering.
France's Cellectis SA owns about 79.1% of Calyxt, a consumer-centric food- and agriculture-focused biotechnology company.
Calyxt launched its IPO in 2017, raising about $64.4 million in gross proceeds.
